TILRAY BRANDS INC (TLRY.CA) Stock Price, Forecast & Analysis

TSX:TLRY • US88688T2096

10.16 CAD
-0.21 (-2.03%)
Last: Feb 12, 2026, 07:00 PM

TLRY.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap1.18B
Revenue(TTM)837.32M
Net Income(TTM)-2.11B
Shares116.00M
Float115.10M
52 Week High32.3
52 Week Low4.85
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-19.49
PEN/A
Fwd PEN/A
Earnings (Next)04-06
IPO2018-07-19
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
TLRY.CA short term performance overview.The bars show the price performance of TLRY.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30

TLRY.CA long term performance overview.The bars show the price performance of TLRY.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of TLRY.CA is 10.16 CAD. In the past month the price decreased by -25.13%. In the past year, price decreased by -23.03%.

TILRAY BRANDS INC / TLRY Daily stock chart

TLRY.CA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
TLRY.CA Full Technical Analysis Report

TLRY.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to TLRY.CA. TLRY.CA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
TLRY.CA Full Fundamental Analysis Report

TLRY.CA Financial Highlights

Over the last trailing twelve months TLRY.CA reported a non-GAAP Earnings per Share(EPS) of -19.49. The EPS decreased by -379% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -100.42%
ROE -133.4%
Debt/Equity 0.18
Chartmill High Growth Momentum
EPS Q2Q%59%
Sales Q2Q%3.11%
EPS 1Y (TTM)-379%
Revenue 1Y (TTM)0.98%
TLRY.CA financials

TLRY.CA Forecast & Estimates

16 analysts have analysed TLRY.CA and the average price target is 17.33 CAD. This implies a price increase of 70.59% is expected in the next year compared to the current price of 10.16.

For the next year, analysts expect an EPS growth of 96.56% and a revenue growth 3.75% for TLRY.CA


Analysts
Analysts71.25
Price Target17.33 (70.57%)
EPS Next Y96.56%
Revenue Next Year3.75%
TLRY.CA Analyst EstimatesTLRY.CA Analyst Ratings

TLRY.CA Ownership

Ownership
Inst Owners11.21%
Ins Owners0.35%
Short Float %N/A
Short RatioN/A
TLRY.CA Ownership

TLRY.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
BHC BAUSCH HEALTH COS INC1.373.063B
GSD DEVONIAN HEALTH GROUP INC N/A1.975B
CRON CRONOS GROUP INC36.351.363B
DHT-UN DRI HEALTHCARE TRUST6.9872.942M
GUD KNIGHT THERAPEUTICS INC124.44585.811M
WEED CANOPY GROWTH CORP N/A534.267M
NGEN NERVGEN PHARMA CORP N/A408.258M
CPH CIPHER PHARMACEUTICALS INC26.58360.761M
TSND TERRASCEND CORP N/A313.013M

About TLRY.CA

Company Profile

TLRY logo image Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in Leamington, Ontario and currently employs 2,842 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.

Company Info

TILRAY BRANDS INC

265 Talbot Street West

Leamington ONTARIO V9X 1J2 CA

CEO: Manfred Ziegler

Employees: 2842

TLRY Company Website

TLRY Investor Relations

Phone: 13026365400

TILRAY BRANDS INC / TLRY.CA FAQ

Can you describe the business of TILRAY BRANDS INC?

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in Leamington, Ontario and currently employs 2,842 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


What is the current price of TLRY stock?

The current stock price of TLRY.CA is 10.16 CAD. The price decreased by -2.03% in the last trading session.


Does TILRAY BRANDS INC pay dividends?

TLRY.CA does not pay a dividend.


How is the ChartMill rating for TILRAY BRANDS INC?

TLRY.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What is the analyst forecast for TLRY.CA stock?

16 analysts have analysed TLRY.CA and the average price target is 17.33 CAD. This implies a price increase of 70.59% is expected in the next year compared to the current price of 10.16.


Can you provide the sector and industry classification for TILRAY BRANDS INC?

TILRAY BRANDS INC (TLRY.CA) operates in the Health Care sector and the Pharmaceuticals industry.